Design, synthesis and mode of action of some benzothiazole derivatives bearing an amide moiety as antibacterial agents

被引:117
作者
Singh, Meenakshi [1 ]
Singh, Sudhir K. [2 ]
Gangwar, Mayank [3 ]
Nath, Gopal [3 ]
Singh, Sushil K. [1 ]
机构
[1] Banaras Hindu Univ, Indian Inst Technol, Dept Pharmaceut, Varanasi 221005, Uttar Pradesh, India
[2] CSIR, Cent Drug Res Inst, Mol & Struct Biol Div, Lucknow 226031, Uttar Pradesh, India
[3] Banaras Hindu Univ, Inst Med Sci, Dept Microbiol, Varanasi 221005, Uttar Pradesh, India
关键词
IN-VITRO; BIOLOGICAL EVALUATION; ANION RECOGNITION; NUCLEASE ACTIVITY; DNA-BINDING; ANTIFUNGAL; RESISTANCE; COMPLEXES;
D O I
10.1039/c4ra02649g
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In this study ten benzothiazole derivatives bearing the amide moiety were designed, synthesized and evaluated for their antibacterial activity and possible mode of action. Structures of the synthesized compounds were elucidated by spectral data. Four different Gram-negative and two different Gram-positive bacterial strains were used in antibacterial activity tests. Among all the synthesised compounds, compound A07 displayed the most potent inhibitory activity with minimum inhibitory concentration (MIC) values of 15.6, 7.81, 15.6, 3.91 mu g ml(-1) against S. aureus, E. coli, S. typhi and K. pneumoniae respectively. Structure-activity relationship (SAR) studies revealed that electronic and lipophillic factors of the phenyl ring had a significant effect on the antimicrobial activity of the designed compounds. The benzothiazole bearing amide (A01-A10) series exhibited different modes of action based on aryl group substitution as revealed by studies on intact bacterial cells and plasmid DNA. The present study provides us two active compounds (A07 and A10) with a membrane perturbing mode of action, and an intracellular mode of action due to binding with DNA along with potent activity against clinically relevant pathogens E. coli and S. aureus.
引用
收藏
页码:19013 / 19023
页数:11
相关论文
共 47 条
[1]  
Alang Gaurav., 2010, Acta Pharmaceutica Sciencia52, P213
[2]   Synthesis, anticonvulsant activity and 3D-QSAR study of some prop-2-eneamido and 1-acetyl-pyrazolin derivatives of aminobenzothiazole [J].
Amnerkar, Nikhil D. ;
Bhusari, Kishore P. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (01) :149-159
[3]   Synthesis and Biological Evaluation of Amidine, Guanidine, and Thiourea Derivatives of 2-Amino(6-trifluoromethoxy)benzothiazole as Neuroprotective Agents Potentially Useful in Brain Diseases [J].
Anzini, Maurizio ;
Chelini, Alessia ;
Mancini, Alessandra ;
Cappelli, Andrea ;
Frosini, Maria ;
Ricci, Lorenzo ;
Valoti, Massimo ;
Magistretti, Jacopo ;
Castelli, Loretta ;
Giordani, Antonio ;
Makovec, Francesco ;
Vomero, Salvatore .
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (02) :734-744
[4]  
Arora P, 2010, J CHEM PHARM RES, V2, P317
[5]   Selective anion recognition by novel 5,10,15,20-tetrakis(o-ferrocenyl-carbonylaminophenyl-substituted) zinc metalloporphyrin receptors [J].
Beer, PD ;
Drew, MGB ;
Jagessar, R .
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS, 1997, (05) :881-886
[6]   SPECTRAL AND ELECTROCHEMICAL ANION SENSING BY A NOVEL 5,10,15,20-TETRAKIS(R-SUBSTITUTED) PORPHYRIN RECEPTOR (R=C6H4NHC(O)C5H4COC5H5+PF6-) [J].
BEER, PD ;
DREW, MGB ;
HESEK, D ;
JAGESSAR, R .
JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1995, (11) :1187-1189
[7]   DICARBOXYLATE ANION RECOGNITION BY A REDOX-RESPONSIVE DITOPIC BIS(COBALTICINIUM) CALIX[4]ARENE RECEPTOR MOLECULE [J].
BEER, PD ;
DREW, MGB ;
HAZLEWOOD, C ;
HESEK, D ;
HODACOVA, J ;
STOKES, SE .
JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1993, (03) :229-231
[8]   Synthesis, anticancer activity and docking of some substituted benzothiazoles as tyrosine kinase inhibitors [J].
Bhuva, Hemal A. ;
Kini, Suvarna G. .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2010, 29 (01) :32-37
[9]   Facile, alternative route to lubeluzole, its enantiomer, and the racemate [J].
Bruno, C ;
Carocci, A ;
Catalano, A ;
Cavalluzzi, MM ;
Corbo, F ;
Franchini, C ;
Lentini, G ;
Tortorella, V .
CHIRALITY, 2006, 18 (04) :227-231
[10]  
Byrd C. M., 2011, PCT Int. Appl., Patent No. [WO 2011002635 A1 20110106, 2011002635]